Smith & Nephew leans on debt for Osiris buy
UK medical equipment manufacturer Smith & Nephew has agreed to buy US firm Osiris Therapeutics using cash and debt, as consolidation in the healthcare sector continues to provide one of the few bright spots for M&A activity this year.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: